Your browser doesn't support javascript.
loading
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.
Westbrook, Thomas C; Guan, Xiangnan; Rodansky, Eva; Flores, Diana; Liu, Chia Jen; Udager, Aaron M; Patel, Radhika A; Haffner, Michael C; Hu, Ya-Mei; Sun, Duanchen; Beer, Tomasz M; Foye, Adam; Aggarwal, Rahul; Quigley, David A; Youngren, Jack F; Ryan, Charles J; Gleave, Martin; Wang, Yuzhuo; Huang, Jiaoti; Coleman, Ilsa; Morrissey, Colm; Nelson, Peter S; Evans, Christopher P; Lara, Primo; Reiter, Robert E; Witte, Owen; Rettig, Matthew; Wong, Christopher K; Weinstein, Alana S; Uzunangelov, Vlado; Stuart, Josh M; Thomas, George V; Feng, Felix Y; Small, Eric J; Yates, Joel A; Xia, Zheng; Alumkal, Joshi J.
Afiliación
  • Westbrook TC; Division of Hematology and Oncology, Department of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Guan X; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Rodansky E; Division of Hematology and Oncology, Department of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Flores D; Division of Hematology and Oncology, Department of Internal Medicine, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Liu CJ; Department of Pathology, Michigan Center for Translational Pathology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Udager AM; Department of Pathology, Michigan Center for Translational Pathology, Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Patel RA; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Haffner MC; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Hu YM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Sun D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Foye A; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Aggarwal R; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Quigley DA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Youngren JF; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Ryan CJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Gleave M; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Wang Y; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Huang J; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Coleman I; Masonic Cancer Center, University of Minnesota; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
  • Morrissey C; Department of Urological Sciences and Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Nelson PS; Department of Urological Sciences and Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Evans CP; Department of Experimental Therapeutics, BC Cancer, University of British Columbia, Vancouver, BC, Canada.
  • Lara P; Duke University, Durham, NC, USA.
  • Reiter RE; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Witte O; Department of Urology, University of Washington, Seattle, WA, USA.
  • Rettig M; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Wong CK; University of California Davis, Davis, CA, USA.
  • Weinstein AS; University of California Davis, Davis, CA, USA.
  • Uzunangelov V; University of California Los Angeles, Los Angeles, CA, USA.
  • Stuart JM; Department of Microbiology, Immunology, and Molecular Genetics at the David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Thomas GV; University of California Los Angeles, Los Angeles, CA, USA.
  • Feng FY; VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
  • Small EJ; UC Santa Cruz Genomics Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
  • Yates JA; UC Santa Cruz Genomics Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
  • Xia Z; UC Santa Cruz Genomics Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
  • Alumkal JJ; UC Santa Cruz Genomics Institute and Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
Nat Commun ; 13(1): 5345, 2022 09 15.
Article en En | MEDLINE | ID: mdl-36109521

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor de Transcripción E2F1 / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Factor de Transcripción E2F1 / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Prognostic_studies Límite: Humans / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido